Cervical Device Contraception-2 (Nanopaz) (NANOPAZ)
June 2, 2008 updated by: Bnai Zion Medical Center
Cervical Device Contraception
Measure blood progesterone by using cervical device contraception.
Study Overview
Detailed Description
A very small cervical device that releases small amount of progesterone 20 mcgm/day.
The target of the research is to measure blood progesterone by using the cervical device.
This small device delivers progesterone by nanotechnology method.
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Phase 2
- Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 2 months (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 10 healthy women are candidate for hysterectomy
Exclusion Criteria:
- Women with neoplastic malignancy disease or thrombophylia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
blood progesterone measure in blood
Time Frame: one to two months
|
one to two months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (ANTICIPATED)
December 1, 2008
Study Completion (ANTICIPATED)
May 1, 2010
Study Registration Dates
First Submitted
May 19, 2008
First Submitted That Met QC Criteria
June 2, 2008
First Posted (ESTIMATE)
June 3, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
June 3, 2008
Last Update Submitted That Met QC Criteria
June 2, 2008
Last Verified
June 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BnaiZionMC-08-BP-003-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.